Stock Analysis

Avecho Biotechnology Full Year 2022 Earnings: AU$0.001 loss per share (vs AU$0.002 loss in FY 2021)

Source: Shutterstock

Avecho Biotechnology (ASX:AVE) Full Year 2022 Results

Key Financial Results

  • Revenue: AU$1.13m (up 42% from FY 2021).
  • Net loss: AU$2.34m (loss narrowed by 31% from FY 2021).
  • AU$0.001 loss per share (improved from AU$0.002 loss in FY 2021).
ASX:AVE Earnings and Revenue History March 17th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Avecho Biotechnology's share price is broadly unchanged from a week ago.

Risk Analysis

Before we wrap up, we've discovered 4 warning signs for Avecho Biotechnology (3 are a bit unpleasant!) that you should be aware of.

Valuation is complex, but we're helping make it simple.

Find out whether Avecho Biotechnology is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis